Lash Group is a subsidiary of Cencora, Inc. and it provides patient support programs to drug manufacturers. Through Lash Group’s partnership with drug manufacturers (see list below), Lash Group, acquired patient data. When Cencora’s network was breached by an unauthorized third party, the patient data of potentially hundreds of thousands of individuals was exfiltrated. The patient data included personally identifiable information and protected health information: names, addresses, dates of birth, diagnoses, medications and prescriptions. Though the date of the breach is unreported, Cencora learned of the breach on or about February 21, 2024 and began sending notifications to impacted individuals on or about May 22, 2024. If you or someone you know has received a notice letter from Cencora, Lash Group, or any of drug manufacturers listed below about the data breach and would like additional information about your legal rights, you can contact Goldenberg Schneider, LPA by calling 513-982-1569, sending an email to [email protected] or completing the “Contact Us” form to the right.
AbbVie Inc. | Acadia Pharmaceuticals Inc. | Bayer Corporation | Bristol Myers Squibb Company and Bristol Myers Squibb Patient Assistance Foundation |
Dendreon Pharmaceuticals LLC | Endo Pharmaceuticals Inc. | Genentech, Inc. | GlaxoSmithKline Group of Companies and the GlaxoSmithKline Patient Access Programs Foundation |
Incyte Corporation | Marathon Pharmaceuticals, LLC/PTC Therapeutics, Inc. | Novartis Pharmaceuticals Corporation | Pharming Healthcare, Inc. |
Regeneron Pharmaceuticals, Inc | Sumitomo Pharma America, Inc. / Sunovion Pharmaceuticals Inc | Tolmar |